Angioedema Pathway for Bangladesh

A bedside worksheet for sorting histamine-mediated from bradykinin-mediated angioedema, choosing the tests that can be done locally, and seeing which treatments are available in Bangladesh.

Signed in as

Doctor sign-in

Sign in with your Google (Gmail) account to open the diagnostic worksheet and your patient register. Your account is created the first time you sign in.

  • You see only the patients you saved.
  • Patient IDs are generated from your Gmail name, for example wasi006-1, wasi006-2.
  • The site administrator can view all records.

The Pathogenesis page is open to everyone without signing in.

Patient register

Loading the register…

1

Patient particulars

Patient IDAssigned on first save

Sex

2

Symptoms

Where is the swelling?

Skin and time course

3

History

Family history of similar swelling

Drugs

Triggers before attacks

Most attacks of hereditary angioedema are spontaneous, so the absence of a trigger does not argue against it.

Underlying disease

4

Clinical impression: which mediator?

The tally is a prompt. The diagnosis is yours: choose the mediator to continue.

Save to register

Saves this patient's details, findings, test results and diagnosis. The patient ID is generated automatically on the first save.

Follow-up

Sign in on the Diagnosis tab to record follow-up visits for your saved patients.

Find the patient

Two mediators, two diseases

HistamineFrom mast cells. Wheals and itching. Fast. Responds to antihistamines, steroids, adrenaline.
BradykininFrom the contact system. No wheals, no itch. Slow, lasts days. Does not respond to those drugs.

Laboratory pattern by type

TypeC4C1-INH levelC1-INH function*C1q
HAE type 1LowLowLowNormal
HAE type 2LowNormalLowNormal
Acquired (AAE)LowLowLowLow
HAE with normal C1-INH (type 3)NormalNormalNormalNormal
ACE inhibitor-inducedNormalNormalNormalNormal
HistaminergicNormalNormalNormalNormal

*The C1-INH function test is not available in Bangladesh. C1q is the test that separates acquired from hereditary disease: low in AAE, normal in HAE.

A common question

In AAE type 1 the C1-INH molecule is normal. Why can it not stop the complement pathway?

So much C1q is activated by immune complexes that C1-INH is used up faster than the liver can replace it.

Then why does the function test come back low, if the molecules are structurally fine?

The test measures the total inhibitory capacity of a fixed volume of plasma: how well 1 mL can stop a standard dose of active C1s enzyme.

Function depends on active concentration. If only 20% of the normal amount of healthy C1-INH is left, 1 mL of plasma can block only 20% of the test enzyme.

Low quantity means low total function. The freshly made molecules work, but there are too few of them in the sample.